Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/053950 stock hub

KOSDAQ/053950 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/053950is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

52B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/053950

In the news

Latest news · KOSDAQ/053950

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E5.4

P25 n/aP50 n/aP75 n/a

ROE-3.3

P25 n/aP50 n/aP75 n/a

ROIC0.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/053950 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

KRW

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	243
Enterprise value	KRW 43.3B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 52B
Price	KRW 3,330
Price currency	KRW
Rev Per Employee	231,211,116.71x
Sic	2834
Symbol	kosdaq/053950
Website	https://www.kyungnampharm.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	18.46%
EV Earnings	4.51x
EV/EBIT	65.16x
EV/EBITDA	15.92x
EV/FCF	-6.6x
EV/Sales	0.77x
FCF yield	-12.61%
P/B ratio	0.46x
P/E ratio	5.42x
P/S ratio	0.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.09%
EBITDA Margin	4.75%
Gross margin	27.62%
Gross Profit	KRW 15.5B
Gross Profit Growth	-20.45%
Gross Profit Growth Q	-30.29%
Gross Profit Growth3 Y	-6.87%
Gross Profit Growth5 Y	-5.45%
Net Income	KRW 9.6B
Pretax Margin	-4.67%
Profit Margin	17.1%
Profit Per Employee	KRW 39.5M
ROA	0.24
Roa5y	-1.19
ROCE	0.51
ROE	-3.29
Roe5y	-7.48
ROIC	0.59
Roic5y	-2.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-19.08%
Cagr15y	-9.27%
Cagr1y	3.26%
Cagr20y	-12.55%
Cagr3y	-21.41%
Cagr5y	-33.17%
Revenue Growth	-9.99x
Revenue Growth Q	-26.03x
Revenue Growth3 Y	-3.54x
Revenue Growth5 Y	1.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.35
Assets	KRW 160.2B
Cash	KRW 44.4B
Current Assets	KRW 72.1B
Current Liabilities	KRW 40.9B
Debt	KRW 35.7B
Debt EBITDA	KRW 13.37
Debt Equity	KRW 0.31
Debt FCF	KRW -5.44
Equity	KRW 113.5B
Interest Coverage	0.48
Liabilities	KRW 46.7B
Long Term Assets	KRW 88.2B
Long Term Liabilities	KRW 5.8B
Net Cash	KRW 8.7B
Net Cash By Market Cap	KRW 16.72
Net Debt EBITDA	KRW -3.26
Net Debt Equity	KRW -0.08
Tangible Book Value	KRW 113.2B
Tangible Book Value Per Share	KRW 7,240
WACC	4.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.76
Inventory Turnover	3.11
Net Working Capital	KRW 18B
Quick ratio	1.43
Working Capital	KRW 31.1B
Working Capital Turnover	KRW 3.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-52.38%
Dividend per share	KRW 0
Last Dividend	KRW 1,000

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-87.96%
1Y total return	3.26%
200-day SMA	3,388.9
3Y total return	-51.46%
50-day SMA	3,614.1
50-day SMA vs 200-day SMA	50over200
5Y total return	-86.66%
All Time High	253,750
All Time High Change	-98.69%
All Time High Date	2007-04-16
All Time Low	2,700
All Time Low Change	23.33%
All Time Low Date	2024-10-30
ATR	373
Beta	0.34
Beta1y	0.1
Beta2y	0.28
Ch YTD	-1.77
High	3,600
High52	5,580
High52 Date	2025-11-06
High52ch	-40.32%
Low	3,320
Low52	2,775
Low52 Date	2025-10-14
Low52ch	20%
Ma50ch	-7.86%
Price vs 200-day SMA	-1.74%
RSI	39.2
RSI Monthly	37.3
RSI Weekly	46.96
Sharpe ratio	0.37x
Sortino ratio	0.8
Total Return	-52.38%
Tr YTD	-1.77
Tr15y	-76.75%
Tr1m	-11.55%
Tr1w	-0.6%
Tr3m	3.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 613.1M
Operating margin	1.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,505,915%
Net Borrowing	-4,798,615,100
Shares Out	15,629,414
Shares Qo Q	16.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -6.6B
Average Volume	741,311x
Bv Per Share	7,261.3
CAPEX	KRW -7.2B
Ch10y	-91.48
Ch15y	-83.56
Ch1m	-11.55
Ch1w	-0.6
Ch1y	3.26
Ch20y	-95.16
Ch3m	3.9
Ch3y	-61.17
Ch5y	-90.57
Ch6m	-23.8
Change	-0.6%
Change From Open	-0.89
Close	3,350
Days Gap	0.3
Depreciation Amortization	2,057,036,000
Dollar Volume	801,594,270
Earnings Date	2026-03-30
EBIT	KRW 613.1M
EBITDA	KRW 2.7B
EPS	KRW 748
F Score	5
FCF	KRW -6.6B
FCF EV Yield	-15.15x
FCF Per Share	KRW -420
Financing CF	19,948,498,330
Fiscal Year End	December
Founded	1,993
Graham Number	11052.82248
Graham Upside	231.9
Income Tax	KRW 676.6M
Investing CF	-1,473,353,360
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-03-31
Last Split Date	2026-04-14
Last Split Type	Reverse
Ma150	3,450.9
Ma150ch	-3.5%
Ma20	3,968.3
Ma20ch	-16.08%
Net CF	19,214,518,810
Open	3,360
P OCF Ratio	86.62
Position In Range	3.57
Ppne	32,723,016,250
Price Date	2026-05-08
Price EBITDA	KRW 19.49
Ptbv Ratio	0.46
Relative Volume	0.32x
Revenue	56,184,301,360x
Tax By Revenue	1.2x
Tr20y	-93.15%
Tr6m	-23.8%
Volume	240,719
Z Score	0.96

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/053950 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/053950 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

KOSDAQ/053950 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.2

Neutral momentum band

Price vs 200-day MA

-1.7%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/053950

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/053950 stock rating?

kosdaq/053950 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/053950 analysis?

The full report lives at /stocks/kosdaq/053950/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/053950?

The latest report frames kosdaq/053950 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/053950 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.